K. Paradis, Tyrosinemia: the Quebec experience, Clin Invest Med, vol.19, issue.5, pp.311-317, 1996.

F. J. Van-spronsen, Y. Thomasse, G. P. Smit, J. V. Leonard, P. T. Clayton et al., Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment, Hepatology, vol.20, issue.5, pp.1187-91, 1994.

F. J. Van-spronsen, G. P. Smit, F. A. Wijburg, Y. Thomasse, and G. Visser, Heymans HS. Tyrosinaemia type I: considerations of treatment strategy and experiences with risk assessment, diet and transplantation, J Inherit Metab Dis, vol.18, issue.2, pp.111-115, 1995.

P. A. Russo, G. A. Mitchell, and R. M. Tanguay, Tyrosinemia: a review, Pediatr Dev Pathol, vol.4, issue.3, pp.212-233, 2001.

A. Masurel-paulet, J. Poggi-bach, R. Mo, O. Bernard, N. Guffon et al., NTBC treatment in tyrosinaemia type I: long-term outcome in French patients, J Inherit Metab Dis, vol.31, issue.1, pp.81-88, 2008.

S. Lindstedt, E. Holme, E. A. Lock, O. Hjalmarson, and B. Strandvik, Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase, Lancet, vol.340, issue.8823, pp.813-820, 1992.

M. Schiff, P. Broue, B. Chabrol, D. Laet, C. Habes et al., Heterogeneity of follow-up procedures in French and Belgian patients with treated hereditary tyrosinemia type 1: results of a questionnaire and proposed guidelines, J Inherit Metab Dis, vol.35, issue.5, pp.823-832, 2012.

H. El-karaksy, M. Rashed, R. El-sayed, M. El-raziky, N. El-koofy et al., Clinical practice. NTBC therapy for tyrosinemia type 1: how much is enough?, Eur J Pediatr, vol.169, issue.6, pp.689-93, 2010.

A. Schlune, E. Thimm, D. Herebian, and U. Spiekerkoetter, Single dose NTBC-treatment of hereditary tyrosinemia type I, J Inherit Metab Dis, vol.35, issue.5, pp.831-837, 2012.

E. Thimm, R. Richter-werkle, G. Kamp, B. Molke, D. Herebian et al., Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC, J Inherit Metab Dis, vol.35, issue.2, pp.263-271, 2012.

T. Ben-omran, Genetic Disorders in Libya, Genetic disorders Among Arab Populations, pp.443-54, 2010.

H. Alobaidy, M. Keasta, and K. Elhoni, Clinical and biochemical analysis with new advance in management, Jamahiriya Med J, vol.3, pp.37-41, 2004.

H. Alobaidy, N. Yahya, and R. Said, Tyrosinemia type I. Clinical and biochemical analysis of cases with poor treatment outcome, Jordan Med J, vol.45, pp.205-216, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-02015328

S. Santra, M. A. Preece, S. A. Hulton, and P. J. Mckiernan, Renal tubular function in children with tyrosinaemia type I treated with nitisinone, J Inherit Metab Dis, vol.31, issue.3, pp.399-402, 2008.

S. Ahmad, J. H. Teckman, and G. T. Lueder, Corneal opacities associated with NTBC treatment, Am J Ophthalmol, vol.134, issue.2, pp.266-274, 2002.